Cite
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT
MLA
Rebecca H. Buckley, et al. “Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.” Biology of Blood and Marrow Transplantation, vol. 23, Mar. 2017, pp. 379–87. EBSCOhost, https://doi.org/10.1016/j.bbmt.2016.12.619.
APA
Rebecca H. Buckley, Jennifer M. Puck, K. Scott Baker, Michael A. Pulsipher, Bénédicte Neven, Andrew C. Dietz, Christine Duncan, Jennifer Heimall, Luigi D. Notarangelo, Elie Haddad, Mary Slatter, Andrew R. Gennery, M.J. Cowan, & Thomas A. Fleisher. (2017). Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Biology of Blood and Marrow Transplantation, 23, 379–387. https://doi.org/10.1016/j.bbmt.2016.12.619
Chicago
Rebecca H. Buckley, Jennifer M. Puck, K. Scott Baker, Michael A. Pulsipher, Bénédicte Neven, Andrew C. Dietz, Christine Duncan, et al. 2017. “Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.” Biology of Blood and Marrow Transplantation 23 (March): 379–87. doi:10.1016/j.bbmt.2016.12.619.